La disponibilidad de Wegovy y Rybelsus , los otros dos medicamentos de la compaa con semaglutida como principio activo, al igual que Ozempic, se mantiene sin cambios, dijo Novo en la nota
Full support throughout your journey for life-changing results Full support throughout your journey for life-changing results Comprehensive support and proven methodology to help you reach your health goals with confidence
Clinical trial results have demonstrated weight loss outcomes that surpass all currently approved obesity medications
Corsetti V, Florenzano F, Atlante A, et al
There are clearly wider cardiovascular effects of the medicine beyond the weight loss and appetite suppressant actions, says Newland-Jones, commenting on the research